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Research
The endocrine-disrupting chemical bis-
phenol A (BPA) has recently garnered height-
ened attention because of widespread human 
exposure and disruption of normal repro-
ductive development in laboratory animals 
[Center for the Evaluation of Risks to Human 
Reproduction (CERHR) 2008; Chapin et al. 
2008; Goodman et al. 2006; European Union 
2003; vom Saal and Hughes 2005]. BPA is 
thought to disrupt normal cell function by 
acting as an estrogen agonist (Wozniak et al. 
2005) as well as an androgen antagonist (Lee 
et al. 2003). In animal studies, prenatal and 
neonatal exposure to BPA has been linked to 
early onset of sexual maturation (Howdeshell 
et al. 1999), altered development and tissue 
organization of the mammary gland (Markey 
et al. 2001), induction of pre  neoplastic mam-
mary gland (Durando et al. 2007) and repro-
ductive tract lesions (Newbold et al. 2007), 
increased prostate size (Timms et al. 2005), 
and decreased sperm production (vom Saal 
et al. 1998) in offspring. Most recently, expo-
sure to BPA has also been associated with 
chronic disease in humans, including cardio-
vascular disease, diabetes, and serum markers 
of liver disease (Lang et al. 2008). 
Orally administered BPA is rapidly 
metabolized by glucuronidation during first-
pass metabolism, with a biological half-life 
of approximately 6 hr and nearly complete 
elimination within 24 hr (Volkel et al. 2002). 
However, because of continuous and wide-
spread exposure,  > 92% of the 2,517 partici-
pants ≥ 6 years of age in the U.S. 2003–2004 
National Health and Nutrition Examination 
Survey (NHANES) had detectable concen-
trations of BPA in their urine (Calafat et al. 
2008). The geometric mean (GM) urinary 
BPA concentration in that study was 2.6 µg/L 
(2.6 µg/g creatinine), and the 95th percentile 
was 15.9 µg/L (11.2 µg/g creatinine).
An important source of human exposure is 
thought to be the ingestion of food and drink 
that has been in contact with epoxy resins 
or polycarbonate plastics (Kang et al. 2006). 
Polycarbonate is a durable, lightweight, and 
heat-resistant plastic, making it popular for 
use in plastic food and beverage containers. 
Indeed, nearly three-fourths of the 1.9 billion 
pounds of BPA used in the United States in 
2003 was used for the manufacture of poly-
carbonate resin (CERHR 2008). Other com-
mon uses of BPA include the manufacture of 
epoxy resins used as composites and sealants 
in dentistry and in the lacquer lining of alumi-
num food and beverage cans (CERHR 2008; 
European Union 2003).
Laboratory studies have demonstrated 
that biologically active BPA is released from 
polycarbonate bottles after simulated normal 
use (Brede et al. 2003; Le et al. 2008). High 
temperatures as well as acidic and alkali solu-
tions cause polymer degradation via hydroly-
sis, resulting in increased BPA migration. After 
incubation for 8, 72, and 240 hr in food-sim-
ulating solvents (10% ethanol at 70°C and 
corn oil at 100°C), mean BPA migration 
increased with incubation time (Onn Wong 
et al. 2005). After a sequence of washing and 
rinsing, Le et al. (2008) found that new poly-
carbonate bottles leached 1.0 ± 0.3 µg/mL 
BPA (mean ± SD) into the bottle content after 
incubation at room temperature for 7 days. 
Although exposure to boiling water increased 
the rate of BPA migration up to 55-fold, used 
bottles did not leach significantly more BPA 
than new ones. However, other studies have 
found that higher concentrations of BPA leach 
from used polycarbonate plastic than from 
new. BPA has been observed to leach from 
polycarbonate animal cages after 1 week of 
incubation at room temperature, with higher 
levels of migration from used versus new cages 
(Howdeshell et al. 2003). Similarly, after incu-
bation in 100°C water for 1 hr, the amount of 
BPA leached from baby bottles subjected to 
simulated use (including dishwashing, boiling, 
and brushing into the bottle) exceeded the 
amount that leached from new baby bottles 
(Brede et al. 2003).
Recently, some polycarbonate bottle manu-
facturers voluntarily eliminated BPA from their 
products (Nalgene Outdoor 2008), and several 
retailers withdrew polycarbonate bottles from 
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Ba c k g r o u n d: Bisphenol A (BPA) is a high-production-volume chemical commonly used in the 
manufacture of polycarbonate plastic. Low-level concentrations of BPA in animals and possibly in 
humans may cause endocrine disruption. Whether ingestion of food or beverages from polycarbonate 
containers increases BPA concentrations in humans has not been studied.
oBjectives: We examined the association between use of polycarbonate beverage containers and 
urinary BPA concentrations in humans.
Me t h o d s : We conducted a nonrandomized intervention of 77 Harvard College students to com-
pare urinary BPA concentrations collected after a washout phase of 1 week to those taken after an 
intervention week during which most cold beverages were consumed from poly  carbonate drinking 
bottles. Paired t-tests were used to assess the difference in urinary BPA concentrations before and 
after polycarbonate bottle use.
re s u l t s: The geometric mean urinary BPA concentration at the end of the washout phase was 
1.2 µg/g creatinine, increasing to 2.0 µg/g creatinine after 1 week of polycarbonate bottle use. 
Urinary BPA concentrations increased by 69% after use of polycarbonate bottles (p < 0.0001). 
The association was stronger among participants who reported ≥ 90% compliance (77% increase; 
p < 0.0001) than among those reporting < 90% compliance (55% increase; p = 0.03), but this dif-
ference was not statistically significant (p = 0.54). 
co n c l u s i o n s: One week of polycarbonate bottle use increased urinary BPA concentrations by two-
thirds. Regular consumption of cold beverages from polycarbonate bottles is associated with a sub-
stantial increase in urinary BPA concentrations irrespective of exposure to BPA from other sources. 
key w o r d s : biomarkers, bisphenol A, endocrine disruptors, human, polycarbonate plastic. Environ 
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their stores altogether (Mui 2008). Canada 
has imposed a ban on the use of BPA in poly-
carbonate baby bottles in order to reduce expo-
sure of infants to BPA (Health Canada 2008), 
and similar legislation is being considered by 
several U.S. states (Austen 2008). However, 
such actions have been largely preemptive, 
as no epidemiologic study has evaluated the 
physio  logic consequences of polycarbonate 
bottle use. Therefore, we studied the impact 
of cold beverage consumption from poly-
carbonate bottles on meas  urable urinary BPA 
concentrations among a Harvard College 
population. We also measured exposure to 
the phenols triclosan (TCS), methyl paraben 
(MePB), propyl paraben (PrPB), and benzo-
phenone-3 (BP-3), which occurs mainly 
through the use of personal care products. 
Therefore, because exposure of these chemicals 
is considered unrelated to polycarbonate bottle 
use, we assessed their association with poly-
carbonate bottle use as a negative control.
Materials and Methods
Study population. We recruited Harvard 
College students in April 2008 via e-mails to 
freshman dormitory, upperclass house, and 
student organization mailing lists. Students 
were directed to a survey website, where 
they provided contact information and indi-
cated their availability for the study dates. 
Participant instructions and informed consent 
forms were also made available. Students at 
least 18 years of age who were available for the 
entire study period were considered eligible 
and were invited to an introductory meeting. 
The 89 students who attended the meeting 
returned their signed informed consent forms, 
provided demographic information (age, sex, 
ethnicity), and received two stainless steel 
bottles. Seven participants withdrew from the 
study before completing the washout phase, 
and five participants withdrew after complet-
ing the washout phase but before completion 
of the intervention phase. Participants who 
withdrew were similar to those who completed 
the study in terms of age (median, 19 years; 
range, 18–22 years) but were slightly more 
likely to be female (66.7%) than students who 
completed the entire study. A total of 77 par-
ticipants completed the study. A $25 com-
pensation was provided only upon completion 
of the study. The study was approved by the 
Human Studies Institutional Review Board of 
Harvard University. The involvement of the 
Centers for Disease Control and Prevention 
(CDC) laboratory was limited and was deter-
mined not to constitute engagement in human 
subjects research.
Study design. The study began with a 7-day 
washout phase designed to minimize exposure 
to BPA by limiting the consumption of cold 
beverages to those contained in stainless steel 
bottles. Because orally administered BPA is 
rapidly excreted (Volkel et al. 2002), we con-
sidered a 1-week washout period sufficient. 
We provided participants with two stainless 
steel bottles and advised them to drink all cold 
beverages from the stainless steel bottles and 
avoid drinking water from #7 poly  carbonate 
plastic cold water dispensers available in col-
lege dining halls. Participants donated urine 
on their choice of 2 of 3 final days of the wash-
out phase. Urine donation took place between 
1700 and 2000 hours on two of the days, and 
between 1600 and 1900 hours on the third 
day. Two poly  carbonate bottles were distrib-
uted to each partici  pant on the second day 
of urine donation during the washout phase. 
Participants were advised to begin drinking all 
cold beverages from the polycarbonate bottles 
(intervention week) immediately. Urine was 
donated again on the participant’s choice of 
2 of 3 final days of the week of polycarbonate 
bottle use between 1700 and 2000 hours. On 
the final day of urine donation, participants 
completed a brief questionnaire in which they 
estimated their percentage compliance during 
the week in which they were asked to drink 
cold beverages from the polycarbonate bottles. 
Stainless steel bottles (27 fluid ounces, with 
#5 polypropylene loop cap) were obtained 
from Kleen Kanteen (763332017107; Chico, 
CA). Polycarbonate bottles [Nalgene 32 fluid 
ounce, Lexan narrow mouth (#53175), and 
Lexan wide mouth (#53107)] were obtained 
from Karst Sports (Shinnston, WV). All par-
ticipants were permitted to keep the bottles 
used in the study.
Urine sample collection. Urine was col-
lected in a polypropylene container, aliquoted, 
and frozen at –20°C. After study completion, 
samples were defrosted at 4°C overnight and 
vortexed; equal volumes of the two samples 
from each phase of the study were then com-
bined and aliquoted. We shipped aliquots of 
samples (blinded to those performing labora-
tory analyses) on dry ice overnight to the CDC 
for measuring BPA and other urinary phenol 
concentrations; samples were also taken to 
N. Rifai (Children’s Hospital, Boston, MA) 
for analysis of urinary creatinine.
Urinary phenol concentrations. Total uri-
nary concentrations (free plus conjugated spe-
cies) of BPA and the other four phenols were 
determined using online solid-phase extraction 
coupled to isotope dilution high-performance 
liquid chromatography (HPLC)-tandem mass 
spectrometry (MS/MS) on a system con-
structed from several HPLC Agilent 1100 
modules (Agilent Technologies, Wilmington, 
DE) coupled to a triple quadrupole API 4000 
mass spectrometer (Applied Biosystems, Foster 
City, CA) (Ye et al. 2005). First, 100 µL 
urine was treated with β-glucuronidase/sul-
fatase (Helix pomatia; Sigma Chemical Co., 
St. Louis, MO) to hydrolyze conjugated spe-
cies of the phenols. The phenols were then 
retained and concentrated on a C18 reversed-
phase size-exclusion solid-phase extraction col-
umn (Merck KGaA, Darmstadt, Germany), 
separated from other urine matrix components 
using a pair of monolithic HPLC columns 
(Merck KGaA), and detected by nega  tive ion-
atmospheric pressure chemical ionization-MS/
MS. The limits of detection (LODs) in a 
0.1-mL urine sample were 0.4 µg/L (BPA and 
BP-3), 0.2 µg/L (PrPB), 1.0 µg/L (MePB), and 
2.3 µg/L (TCS). Low-concentration (~ 4 to 
~ 25 µg/L) and high-concentration (~ 10 to 
~ 65 µg/L) quality-control materials, prepared 
with pooled human urine, were analyzed with 
standard, reagent blank, and unknown samples 
(Ye et al. 2005). Creatinine was measured by a 
rate-blanked method using the Hitachi 917 
analyzer and Roche Diagnostics reagents (both 
from Roche Diagnostics, Indianapolis, IN).
Statistical analysis. Urinary phenol concen-
trations were normalized for dilution using the 
formula 100 × urinary phenol concentration 
(micro  grams per liter) ÷ creatinine concen-
tration (milli  grams per deci  liter). Creatinine-
adjusted phenol concentrations (micrograms 
per gram creatinine) were not normally dis-
tributed and were therefore log-transformed. 
Phenol concentrations < LOD were assigned 
a value equal to one-half the LOD (Hornung 
1990) prior to creatinine adjustment. 
We calculated GMs for creatinine- 
corrected concentrations. We used paired 
t-tests to examine the association between 
log-transformed urinary creatinine-adjusted 
phenol concentrations and drinking-container 
assignment overall and within subsets defined 
by percent compliance during the inter-
vention phase (≥ median and < the median). 
When the participant reported compliance as 
a range, we used the mean. Two sample t-tests 
were used to make comparisons between the 
strata defined by percent compliance. 
Results
The study population included 77 subjects 
who ranged in age from 18 to 23 years, with 
a median of 19 years (Table 1). On the basis 
Table 1. Characteristics of 77 Harvard College 
students enrolled in a nonrandomized intervention 
study assessing changes in urinary phenol con-




  Male 41 (53.2)
  Female 36 (46.8)
Ethnicity
  Caucasian 30 (39.0)
  Asian 38 (49.3)
  African American 5 (6.5)
  Hispanic 4 (5.2)
Percent compliance [median  90 (50–100)
  of proportion (range)]
Age, years [median (range)] 19 (18–23)Carwile et al.
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of self-reported data, we cate  gorized race/ 
ethnicity into four groups: Caucasian, Asian, 
African American, and Hispanic. Thirty par-
ticipants (39.0%) were Caucasian, 38 were 
of Asian descent (49.4%), 5 were African 
American (6.5%), and 4 were Hispanic 
(5.2%). Forty-one subjects were male (53.3%). 
Protocol compliance for the week in which 
participants drank from polycarbonate bottles 
ranged from 50% to 100% but was generally 
high, with a median of 90%.
Nine samples (11.7%) from the washout 
week and three samples (3.9%) from the inter-
vention week (period in which participants 
drank from polycarbonate bottles) had BPA 
concentrations < LOD. BP-3 and MePB were 
detected in all participants, and PrPB was 
detected in all but one participant each week. 
TCS was detected in 75.3% of the samples 
taken at the end of the washout week and in 
74.0% of the samples collected after the inter-
vention week. The GM concentration of BPA 
was 1.3 µg/L (1.2 µg/g creatinine) during the 
washout period and 2.1 µg/L (2.0 µg/g creati-
nine) during the intervention week (Table 2). 
GM concentrations for the washout phase and 
intervention week were 46.1 and 66.8 µg/g 
creatinine for BP-3; 51.3 and 48.4 µg/g crea-
tinine for MePB; 8.4 and 8.8 µg/g creatinine 
for PrPB; and 15.5 and 17.3 µg/g creatinine 
for TCS, respectively. 
Table 3 presents results from paired t-tests 
comparing urinary BPA concentrations in 
weeks 1 and 2. Urinary BPA concentrations 
increased by 69% after polycarbonate bottle 
use. We observed a larger difference between 
the intervention and washout weeks in the 
stratum with intervention compliance ≥ 90% 
(77% increase; p < 0.0001) relative to the stra-
tum with compliance < 90% (55%; p = 0.03); 
however, the strata were not significantly dif-
ferent from each other (p = 0.54). Of the other 
phenols, only urinary BP-3 concentration was 
associated with polycarbonate bottle use, with 
relatively higher concentrations observed after 
use of poly  carbonate bottles (45% increase; 
p = 0.001). A slightly larger change in BP-3 
concentration was observed in the less 
compliant stratum (64% increase; p = 0.01) 
relative to the more compliant stratum (36% 
increase; p = 0.04); however, this difference 
was not statistically significant (p = 0.42).
Discussion
Several previous studies have demonstrated 
that biologically active BPA is released from 
polycarbonate bottles into the bottle content 
after simulated normal use (Brede et al. 2003; 
Le et al. 2008). However, to our knowledge, 
the present study is the first to quantify the 
corresponding increase in urinary BPA con-
centrations after use of polycarbonate drinking 
bottles. Thus, this study suggests that BPA-
containing drinking vessels release sufficient 
amounts of BPA into the bottle content to 
significantly raise the amount of BPA excreted 
in urine in humans who drink from these bot-
tles. Specifically, in this study of 77 Harvard 
College students, urinary BPA concentrations 
were higher when participants consumed the 
majority of cold beverages from poly  carbonate 
bottles compared with a washout phase in 
which polycarbonate bottles were avoided. 
This statistically significant increase was 
observed despite background BPA exposure 
from other sources, which was not assessed 
nor controlled in this study. This association 
persisted after stratification by self-reported 
compliance during the intervention week, with 
a nonsignificantly larger difference between 
intervention and washout phase urinary BPA 
concentrations among participants reporting 
higher percent compliance. Of interest, the 
urinary BPA concentrations reported for this 
group of students (both before and after the 
intervention) were similar to those reported 
for the U.S. general population (Calafat et al. 
2008) and selected populations in Southeast 
Asia (Kim et al. 2003; Matsumoto et al. 2003; 
Ouchi and Watanabe 2002; Yang et al. 2003).
Because of BPA’s short half-life and rapid 
elimination (Volkel et al. 2002), carry  over of 
ingested BPA between the washout phase and 
intervention phase was considered unlikely. It 
is possible that certain subject characteristics 
may have varied between the 2 weeks, produc-
ing a period effect that was unaccounted for by 
our analyses. We considered this improbable 
because of the lack of variability in the routine 
of under  graduate students, who attended the 
same classes and ate in the same campus din-
ing halls each week. Additionally, the similar-
ity of observed urinary BPA concentrations 
to national levels suggests that subjects were 
exposed to typical amounts of BPA from other 
sources during both weeks. Moreover, fatigue 
and the participants’ exposure to mass media 
concerning the leaching of BPA from poly-
carbonate bottles might have induced better 
compliance during the washout phase than the 
intervention phase, thus leading to an under-
estimate of the impact of poly  carbonate bottle 
use on urinary BPA concentrations. It is also 
possible that participants may have modified 
their behavior during the week of polycarbon-
ate bottle use to reduce BPA exposure from 
other sources. However, other sources of BPA 
exposure have not been well publicized, and 
any reduction in exposure to other sources of 
BPA during the intervention week would have 
reduced the observed effect estimate.
We used spot urine samples for conve-
nience; however, disadvantages of this method 
include interperson variability in BPA con-
centration and variability in the volume of 
urine (Barr et al. 2005). Two equal-volume 
Table 2. GM concentrations of phenols (µg/creatinine) 
after washout and intervention.
Phenol Week of study GM (95% CI)
BPA Washout 1.2 (1.0–1.4)
Intervention 2.0 (1.7–2.4)
BP-3 Washout 46.1 (30.6–69.5)
Intervention 66.8 (42.3–105.5)
MePB Washout 51.3 (37.3–70.7)
Intervention 48.4 (36.2–64.8)
PrPB Washout  8.4 (5.4–12.9)
Intervention 8.8 (5.8–13.1)
TCS Washout 15.5 (9.5–25.3)
Intervention 17.3 (10.7–28.1)
Concentrations (µg/L) < LOD were recorded as 1/2 LOD, 
which is 0.2 for BPA and BP-3; 1.15 for TCS; 0.5 for MePB; 
and 0.1 for PrPB.
Table 3. Percent change in urinary concentrations of phenols associated with 1-week use of polycarbonate 
drinking containers.
Phenol Percent change (95% CI) p-Value p for heterogeneity
BPA
  Overall 69 (40 to 102) < 0.0001
  ≥ 90% compliance 77 (45 to 117) < 0.0001
  < 90% compliance 55 (6 to 127) 0.03 0.54
BP-3
  Overall 45 (16 to 81) 0.001
  ≥ 90% compliance 36 (2 to 80) 0.04
  < 90% compliance 64 (11 to 142) 0.01 0.42
MePB
  Overall –6 (–25 to 18) 0.60
  ≥ 90% compliance 17 (–10 to 51) 0.24
  < 90% compliance –34 (–56 to 0) 0.05 0.01
PrPB
  Overall 5 (–24 to 44) 0.77
  ≥ 90% compliance 15 (–23 to 70) 0.49
  < 90% compliance –10 (–49 to 59) 0.70 0.46
TCS
  Overall 12 (–17 to 50) 0.46
  ≥ 90% compliance 11 (–18 to 50) 0.50
  < 90% compliance 17 (–39 to 126) 0.62 0.88
Concentrations (µg/L) < LOD were recorded as 1/2 LOD, which is 0.2 for BPA and BP-3; 1.15 for TCS; 0.5 for MePB; and 0.1 
for PrPB. Twenty-eight participants reported < 90% compliance over intervention week, 48 participants reported ≥ 90% com-
pliance, and compliance was missing for one participant. Polycarbonate bottle use and urinary BPA
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samples from each week were combined to 
minimize day-to-day variability. Additionally, 
we collected all urine samples in the evening, 
minimizing variability related to time of day 
(Mahalingaiah et al. 2008). Concern regard-
ing interperson variability is also mitigated by 
recent findings that a single urinary BPA con-
centration was predictive of long-term exposure 
on a scale of weeks to months (Mahalingaiah 
et al. 2008). Urinary BPA concentrations were 
creatinine-adjusted to account for variability 
in urine dilution. Overall, the results obtained 
after the analysis with and without correc-
tion of the urinary dilution were fairly similar. 
However, failure to control for urinary creati-
nine concentrations resulted in a greater degree 
of within-person variation and, subsequently, 
decreased precision, as evidenced by wider 
95% CIs. For this reason, we have presented 
only the creatinine-adjusted results.
To account for the possibility of a chance 
finding, we also compared the impact of poly-
carbonate bottle use on several phenols not 
thought to be associated with poly  carbonate 
bottle use. As expected, we observed no dif-
ference for MePB, PrPB, or TCS, although 
urinary concentrations of BP-3 were higher 
after poly  carbonate bottle use. However, after 
stratification by percent compliance during the 
intervention week, the association for BP-3 was 
stronger in the less compliant group. By con-
trast, the association between BPA and poly-
carbonate bottle use was stronger in the more 
compliant group, suggesting that BPA may 
leach from polycarbonate bottles. We found 
BPA and BP-3 to be strongly correlated: The 
Pearson correlation coefficients between BP-3 
and BPA were 0.38 (p = 0.0008) and 0.43 
(p = 0.0001) during the washout week and 
intervention week, respectively. Although this 
study was not designed to look at other sources 
of BPA, or any sources of the other phenols, 
we hypothesize that the strong correlation 
observed between BPA and BP-3 could be the 
result of a shared source or behavior. We are 
not aware of the presence of BP-3—a common 
sunscreen agent in personal care products—in 
polycarbonate plastic, although it can also be 
used as ultraviolet stabilizer in plastic surface 
coatings for food packaging to prevent poly-
mer or food photo  degradation (Suzuki et al. 
2005). However, because sources and routes of 
exposure for many of these compounds are not 
yet known, it is possible that BPA and BP-3 
are used in a common product that has not 
yet been identified. An alternative explanation 
is that students who participated in the most 
outdoor physical activity drank the most fluid 
from their bottles and also applied the most 
sunscreen, potentially increasing both BPA and 
BP-3 levels. 
Our study population included a high pro-
portion of Asian and Caucasian participants, 
and our participants were young. However, 
there is no obvious reason why the results of 
our study should not apply to other ethnici-
ties and age groups. Furthermore, the use of 
polycarbonate bottles is very popular among 
college students, making this an especially 
relevant population to study. Although we 
assessed the effect of the exclusive use of poly-
carbonate plastic bottles as beverage contain-
ers, a proportionate increase in urinary BPA 
would be expected among individuals who 
use polycarbonate plastic bottles in combina-
tion with other beverage containers. Children 
have been found to have higher urinary BPA 
concentrations than adolescents and adults 
(Calafat et al. 2008), consistent with animal 
evidence of reduced glucuronidation in fetuses 
and neonates (Matsumoto et al. 2002). Thus, 
because of their reduced ability to clear BPA, 
we predict that children would have higher 
urinary BPA concentrations due to use of 
polycarbonate plastic bottles relative to the 
study population. 
The major strength of this study is the non-
randomized intervention design. We compared 
urinary BPA concentrations within each partic-
ipant, which precluded confounding by subject 
characteristics that remain constant over time. 
Although within-person confounding was pos-
sible, it is unlikely that unmeasured confound-
ing could account for the large effect estimate 
we observed. The large increase in mean uri-
nary BPA concentration after regular use of 
polycarbonate bottles suggests that the systema-
tic BPA variation in the two study phases was 
by far greater than any random variation due 
to BPA ingestion from other sources. 
Furthermore, we assessed the impact of 
polycarbonate bottle use in a normal use   
setting. The present study could be consid-
ered a conservative estimate of true use, as 
students did not have access to dish  washers 
and were instructed to use their containers 
for cold beverages only, whereas the storage of 
hot liquids is common, especially in outdoor 
recreation settings. Because heating is thought 
to increase the amount of BPA leached from 
the polycarbonate (Le et al. 2008), we would 
anticipate higher urinary BPA concentrations 
after ingestion of hot beverages stored in the 
same bottles. 
Conclusions 
To our knowledge, this is the first study to 
assess the impact of polycarbonate drinking 
bottle use on urinary BPA concentrations. 
Despite within-person variability resulting 
from other sources of BPA exposure, a meas-
urable increase in urinary BPA resulted from 
only 1 week of exposure to beverages con-
tained in polycarbonate bottles. Replication 
of this study in other populations may help to 
inform public health policy regarding the use 
of BPA in polycarbonate food and beverage 
containers. 
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